Living Longer with Immunotherapy for Advanced Prostate Cancer
by on Thursday, February 9th, 2012 | No Comments
In this video interview from the ASCO (American Society of Clinical Oncology) Genitourinary Cancers Symposium, Dr. Chadi Nabhan explores the phase III results of the IMPACT study. The study results suggest that treating advanced prostate cancer with active immunotherapy may increase survival even longer that previously documented. He also discusses promising research and treatments in development, and why he feels this is an “exciting time for men with prostate cancer.”
Go here to see the original: Living Longer with Immunotherapy for Advanced Prostate Cancer